Skip to main content
. 2001 May;158(5):1703–1711. doi: 10.1016/S0002-9440(10)64126-0

Figure 3.

Figure 3.

Chemotactic activity of CXCL10 on BAL T cells purified from three representative patients with A1-A3 rejection episodes and a patient with active BOS. The assays were performed using a modified Boyden chamber in triplicate and data are given as mean ± SD. CXL10 shows significant chemotactic activity on BAL T cells (A–D) and the CXCR3+ T cell clone (E). The number of BAL T cells migrating in response to CXCL10 was higher in patients with A2-A3 grade rejection than in patients with lower grade rejection (A1). Because of the limited number of patients evaluated the difference was not significant.